Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

NCT06061640 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Zhejiang Chinese Medical University as lead sponsor.

NCT NCT06061640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06061640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Value and Impact of Diagnostic Biomarkers for MAFLD Using Machine Learning Methods
Lead sponsor
The First Affiliated Hospital of Zhejiang Chinese Medical University
Phase
Observational
Overall status
Unknown status
Start date
June 1, 2023
Completion date
December 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated fatty liver disease